Recently, The Journal of Molecular Diagnostics has published a medical research that claims of a 72 hr detection blood test tool for Non-Small-Cell Lung Cancer. This kind of an advanced detection tool will be helpful for the patients as well as medical practioners for selection of best possible treatment solutions. This technique will reduce the death rate by ensuring faster treatment as well as lessening disease severity.
